Benzinga | Jan 25, 2022 10:20AM EST

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $21

Morgan Stanley maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $25 to $21.